From Bio Co

From Bio Co Equity

The The Equity of From Bio Co (377220.KQ) as of Oct 10, 2026 is 28.03 B KRW. In the previous year, The Equity was 50.24 B KRW — a change of -44.22% (lower).

Equity

28.03 BKRW

YoY

-44.22%

Last updated:

In 2025, From Bio Co's equity was 28.03 B KRW, a -44.22% increase from the 50.24 B KRW equity in the previous year.

The From Bio Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-10.21 B KRW
Jan 1, 2020
23.64 B KRW
Jan 1, 2021
84.43 B KRW
Jan 1, 2022
87.96 B KRW
Jan 1, 2023
76.64 B KRW
Jan 1, 2024
50.24 B KRW
Jan 1, 2025
28.03 B KRW
The From Bio Co Equity history
YEAREquityYoY
28.03 BKRW-44.22%
50.24 BKRW-34.45%
76.64 BKRW-12.86%
87.96 BKRW+4.18%
84.43 BKRW+257.14%
23.64 BKRW-331.53%
-10.21 BKRW—
Access this data via the Eulerpool API
Get Free API Key

From Bio Co Stock analysis

What does From Bio Co do? From Bio Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing From Bio Co's Equity

From Bio Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding From Bio Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating From Bio Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

From Bio Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in From Bio Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about From Bio Co stock

The Equity of From Bio Co is 28.03 B KRW in 2025.

The Equity of From Bio Co changed from 50.24 B KRW to 28.03 B KRW, representing a -44.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity From Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's From Bio Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — From Bio Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — From Bio Co